Mucosal trafficking of vector-specific CD4+ T lymphocytes following vaccination of rhesus monkeys with adenovirus serotype 5.
about
Induction of intestinal immunity by mucosal vaccines as a means of controlling HIV infectionDecreased pre-existing Ad5 capsid and Ad35 neutralizing antibodies increase HIV-1 infection risk in the Step trial independent of vaccinationAdenoviral vectors as novel vaccines for influenza.Human immunodeficiency virus vaccine trialsPreferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individualsAntibody persistence and T-cell balance: two key factors confronting HIV vaccine development.Increase in DNA vaccine efficacy by virosome delivery and co-expression of a cytolytic protein.Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humansInterleukin-encoding adenoviral vectors as genetic adjuvant for vaccination against retroviral infectionHeterologous prime-boost regimens with a recombinant chimpanzee adenoviral vector and adjuvanted F4 protein elicit polyfunctional HIV-1-specific T-Cell responses in macaques.Durable mucosal simian immunodeficiency virus-specific effector memory T lymphocyte responses elicited by recombinant adenovirus vectors in rhesus monkeysDNA/NYVAC vaccine regimen induces HIV-specific CD4 and CD8 T-cell responses in intestinal mucosa.TRIM5α does not affect simian immunodeficiency virus SIV(mac251) replication in vaccinated or unvaccinated Indian rhesus macaques following intrarectal challenge exposureSexual risk behaviors, circumcision status, and preexisting immunity to adenovirus type 5 among men who have sex with men participating in a randomized HIV-1 vaccine efficacy trial: step studyAccelerated heterologous adenovirus prime-boost SIV vaccine in neonatal rhesus monkeys.Adenovirus serotype 26 utilizes CD46 as a primary cellular receptor and only transiently activates T lymphocytes following vaccination of rhesus monkeys.Risk of immunodeficiency virus infection may increase with vaccine-induced immune response.Mucosal vaccination with a live recombinant rhinovirus followed by intradermal DNA administration elicits potent and protective HIV-specific immune responses.Modeling pre-existing immunity to adenovirus in rodents: immunological requirements for successful development of a recombinant adenovirus serotype 5-based ebola vaccine.Adenovirus serotype 26 and 35 vectors induce simian immunodeficiency virus-specific T lymphocyte responses in foreskin in rhesus monkeys.HIV-specific CD4 T cells and immune control of viral replication.HIV vaccines: a brief overview.Adenovirus-vectored Ebola vaccines.A dendritic cell targeted vaccine induces long-term HIV-specific immunity within the gastrointestinal tract.The two faces of vaccine-induced immune response: protection or increased risk of HIV infection?!Vaccination with recombinant adenovirus expressing peste des petits ruminants virus-F or -H proteins elicits T cell responses to epitopes that arises during PPRV infection.Conserved HIV Epitopes for an Effective HIV Vaccine.
P2860
Q27001897-EE87B720-B32B-4338-ADAF-73978CFA757CQ28730757-6A2A62F9-7797-4DFD-9EF8-9554624FFE83Q30370445-D0CBD135-76B4-49FE-A7F7-4D51DABAA217Q30424366-0E1154C8-E3A4-4389-9315-9AE94B8BDDB2Q34218500-DF3BB460-E9D8-44A1-9E0F-064BCADE55FFQ34480617-36D74A77-C3BF-4F64-9CB8-99EABCA5ED4EQ34511631-22CF134A-0ED7-4506-AF09-57AD177719E1Q35055188-D3C9A518-6044-4041-A860-0A20914246C2Q35070346-1E415B72-0E0E-412A-BDAD-CF68AFB04B2FQ35344875-C5936B9F-7CD1-4551-923E-B8AE1A804B76Q35363320-F95944B3-7AF5-4378-ABB0-A5E7298B14C6Q35382338-5C742664-CFE5-4678-A943-F79C21604C64Q35531415-168B99CF-8A96-4B31-BCF8-EB9EF9341BB7Q36084253-FA622CF3-0C91-4D2A-B59D-003E9E7B4002Q36171869-F30DC5B6-87AC-4B91-9516-254A2C26BAA0Q36276518-48567B1F-382A-4217-8600-C349141C1D34Q36276637-F8D391B9-E09E-4736-A1F6-61D4C1D2A7D5Q37419985-C5B7DAF9-C5E0-4FCD-A21F-E1C315C425B3Q37627897-9A85F283-7C19-4A71-919E-EB15EE70AF6EQ37713545-62F07CDF-1103-4625-8B04-97CADFAD3407Q37866624-DA7AF61D-922F-426B-BDFB-DC0CFF6B52B7Q38210557-7F060EDF-547B-4D0B-9940-1179F6DEF729Q38569831-C1C6337A-9659-42EA-A3C8-22D6E4055629Q40844843-566A2748-E25F-483A-AD37-C6492FDFA71AQ42241791-A2ABFFD1-34FA-42E7-948A-BD9E495FCC04Q45324559-ED764A7E-D755-439B-8ADE-4A5D43D316E7Q47093684-8D77A308-B20F-4162-A047-EE53A1785EBE
P2860
Mucosal trafficking of vector-specific CD4+ T lymphocytes following vaccination of rhesus monkeys with adenovirus serotype 5.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Mucosal trafficking of vector- ...... ys with adenovirus serotype 5.
@ast
Mucosal trafficking of vector- ...... ys with adenovirus serotype 5.
@en
Mucosal trafficking of vector- ...... ys with adenovirus serotype 5.
@nl
type
label
Mucosal trafficking of vector- ...... ys with adenovirus serotype 5.
@ast
Mucosal trafficking of vector- ...... ys with adenovirus serotype 5.
@en
Mucosal trafficking of vector- ...... ys with adenovirus serotype 5.
@nl
prefLabel
Mucosal trafficking of vector- ...... ys with adenovirus serotype 5.
@ast
Mucosal trafficking of vector- ...... ys with adenovirus serotype 5.
@en
Mucosal trafficking of vector- ...... ys with adenovirus serotype 5.
@nl
P2093
P2860
P356
P1433
P1476
Mucosal trafficking of vector- ...... ys with adenovirus serotype 5.
@en
P2093
Angela Carville
Annalena La Porte
James B Whitney
Jinyan Liu
Kara L O'Brien
Katherine Masek-Hammerman
Keith G Mansfield
P2860
P304
P356
10.1128/JVI.01157-10
P407
P577
2010-08-04T00:00:00Z